On Monday, February 24, the next meeting of the Transparency Council.
Agenda:
- Evaluation of the drug Qinlock (ripretinibum)
- Drug program: "Treatment of patients with advanced gastrointestinal submucosal tumor (GIST)".
- ICD-10: C15, C16, C17, C18, C20, C48
- Evaluation of the drug Ebglyss (lebrikizumabum)
- Drug program B.124: "Treatment of pati...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
If you already have an account, please log in
- Drug program B.124: "Treatment of pati...
